People

Aerami Therapeutics has issued a statement following the death of CEO Lisa Yañez, who was killed in a car accident on May 2, 2023 in Chapel Hill, NC, USA, offering condolences to Yañez's family and announcing that former CEO and current Executive Chairwoman Anne Whitaker will assume leadership of the company. Yañez joined Aerami in June 2022 as Chief Operating … [Read more...] about Following the sudden death of CEO Lisa Yañez, Anne Whitaker will lead Aerami

ReCode Therapeutics, which is developing inhaled mRNA therapeutics for the treatment of primary ciliary dyskinesia and cystic fibrosis, has named John G. Matthews as Senior VP of Clinical Development. ReCode initiated a Phase 1 trial of its RCT1100 nebulized DNAI1 mRNA in March 2023. A pulmonologist, Matthews has extensive experience in respiratory disease research … [Read more...] about ReCode Therapeutics hires John G. Matthews as Senior VP of Clinical Development

HCmed Innovations announced that former AstraZeneca Science and Innovation Director of Inhaled Drug Delivery Gunilla Petersson has joined the company as Chief Scientific Officer. Petersson has almost 30 years of experience in the pharmaceutical industry, primarily in inhaled drug development. Taipei-based HCmed launched the Pulmogine handheld mesh nebulizer in … [Read more...] about Gunilla Petersson joins HCmed as Chief Scientific Officer

Former Arranta Bio CEO David Stevens has joined CDMO Kindeva Drug Delivery as Chief Commercial Officer, the company said. Prior to Arranta, Stevens held a variety of roles at Albany Molecular Research, Aptuit, and Charles River Laboratories. Kindeva (formerly 3M Drug Delivery Systems) merged with Meridian Medical Technologies in late 2022. The company's recent … [Read more...] about Kindeva Drug Delivery names David Stevens as Chief Commercial Officer

MannKind Corporation has named former Acorda Therapeutics COO Lauren Sabella  as Executive VP, Chief Operating Officer. Sabella's experience includes 12 years at Acorda, first as Chief Commercial Officer and then as COO; she previously served in a number of roles at Boehringer Ingelheim, including as Executive Director of Marketing for the Respiratory Franchise and as … [Read more...] about MannKind names Lauren Sabella as Executive VP, COO

Utuly intranasal epinephrine developer Bryn Pharma has named Sandy Loreaux as CEO, succeeding David Dworaczyk, who will remain with the company as head of R&D, regulatory, and production. Loreaux was most recently US President of Covis Pharma and previously held executive positions at Mallinckrodt, Valeant, and Sanofi-Aventis. Bryn recently announced results … [Read more...] about Bryn Pharma names Sandy Loreaux as CEO

AuraVax Therapeutics, which is developing intranasal antiviral technology licensed from Massachusetts General Hospital and the University of Houston, has named former Merck executive Joseph C. Sullivan as the company's first CEO. Sullivan was most recently Chief Commercial Officer at Nature's Toolbox and previously served in various roles at Merck in vaccines, … [Read more...] about AuraVax names Joseph Sullivan as CEO

Inhaled drug developer Savara has announced the appointments of former Strongbridge Biopharma executives Scott Wilhoit as Executive VP, Global Commercial, and Rob Lutz as Chief Operating Officer. The company also said that it had promoted Dave Lowrance from Chief Financial Officer to Chief Financial and Administrative Officer. Wilhoit, who has been a part-time … [Read more...] about Savara announces management changes